Release Date: 29/12/22 18:43 Summary: Estimated Distribution Announcement Price Sensitive: Yes Download Document 224.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%